The Effect of Piracetam Administration on Cerebral Palsy Prevention in Rat Fetuses Born To Pregnant Rats by Determining Bdnf Levels in Brain Tissue

Cerebral palsy is the most common cause of disability in children worldwide, estimated prevalence of 1.5–4 per 1000 children; the  higher prevalence in low-resource populations (up to 10 per 1000 children). Brain-derived neurotrophic factor (BDNF) is potent modulator of many neuronal functions that...

Full description

Saved in:
Bibliographic Details
Main Authors: Dudy Aldiansyah, Sarma Nursani Lumbanraja, Khairul Putra Surbakti, Isti Ilmiati Fujiati, Agus Sulistyono
Format: Article
Language:English
Published: University of Baghdad, College of Science for Women 2024-12-01
Series:مجلة بغداد للعلوم
Subjects:
Online Access:https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/9588
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849707724635373568
author Dudy Aldiansyah
Sarma Nursani Lumbanraja
Khairul Putra Surbakti
Isti Ilmiati Fujiati
Agus Sulistyono
author_facet Dudy Aldiansyah
Sarma Nursani Lumbanraja
Khairul Putra Surbakti
Isti Ilmiati Fujiati
Agus Sulistyono
author_sort Dudy Aldiansyah
collection DOAJ
description Cerebral palsy is the most common cause of disability in children worldwide, estimated prevalence of 1.5–4 per 1000 children; the  higher prevalence in low-resource populations (up to 10 per 1000 children). Brain-derived neurotrophic factor (BDNF) is potent modulator of many neuronal functions that protect the newborn or developing brain from ischemic injury. The expression of GluN3A, which plays a neuroprotective role, is rapidly induced during cerebral ischemia and hypoxia. This study assessed the effect of piracetam administration on BDNF and GluN3A levels in the brain tissue to determine its potential to prevent cerebral palsy. In this experimental study with a post-test-only control group design, a rat model of cerebral palsy was established by injecting pregnant rats with LPS on gestation days 15, 17, and 19; piracetam was administered orally on day 10.5. BDNF and GluN3A protein levels and mRNA expression in the foetal brain tissue of 36 subjects were evaluated with enzyme-linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (RT-PCR). BDNF and GluN3A protein levels in the foetal brain differed significantly between the control and treatment groups (p < 0.05). A decrease in the mRNA and protein levels of BDNF and GluN3A was observed in all treatment groups, but the statistical analysis of RT-PCR did not reveal significant differences between the control and treatment groups (p > 0.05). These results indicate that piracetam can prevent cerebral palsy in a foetal rat model established via prenatal LPS injection, as assessed by the protein expression of BDNF and GluN3A mRNA.
format Article
id doaj-art-090140c208db4edeb166897c5ebca290
institution DOAJ
issn 2078-8665
2411-7986
language English
publishDate 2024-12-01
publisher University of Baghdad, College of Science for Women
record_format Article
series مجلة بغداد للعلوم
spelling doaj-art-090140c208db4edeb166897c5ebca2902025-08-20T03:15:51ZengUniversity of Baghdad, College of Science for Womenمجلة بغداد للعلوم2078-86652411-79862024-12-012112(Suppl.)10.21123/bsj.2024.9588The Effect of Piracetam Administration on Cerebral Palsy Prevention in Rat Fetuses Born To Pregnant Rats by Determining Bdnf Levels in Brain TissueDudy Aldiansyah0https://orcid.org/0000-0001-9601-2855Sarma Nursani Lumbanraja1Khairul Putra Surbakti 2Isti Ilmiati Fujiati3Agus Sulistyono4Philosophy Doctor in Medicine Program, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. and Department of Obstetrics and Gynaecology, Medical Faculty, Universitas Sumatera Utara, Medan, Indonesia./Department of Obstetrics and Gynaecology, Medical Faculty, Universitas Sumatera Utara, Medan, Indonesia.Department of Obstetrics and Gynaecology, Medical Faculty, Universitas Sumatera Utara, Medan, Indonesia.Departement of Neurology, Medical Faculty, Universitas Sumatera Utara, Medan, Indonesia.Department of Community Medicine, Public Health, Faculty of Medicine, Universitas Sumatera Utara, Medan Indonesia.Department Obstetrics & Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia. Cerebral palsy is the most common cause of disability in children worldwide, estimated prevalence of 1.5–4 per 1000 children; the  higher prevalence in low-resource populations (up to 10 per 1000 children). Brain-derived neurotrophic factor (BDNF) is potent modulator of many neuronal functions that protect the newborn or developing brain from ischemic injury. The expression of GluN3A, which plays a neuroprotective role, is rapidly induced during cerebral ischemia and hypoxia. This study assessed the effect of piracetam administration on BDNF and GluN3A levels in the brain tissue to determine its potential to prevent cerebral palsy. In this experimental study with a post-test-only control group design, a rat model of cerebral palsy was established by injecting pregnant rats with LPS on gestation days 15, 17, and 19; piracetam was administered orally on day 10.5. BDNF and GluN3A protein levels and mRNA expression in the foetal brain tissue of 36 subjects were evaluated with enzyme-linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (RT-PCR). BDNF and GluN3A protein levels in the foetal brain differed significantly between the control and treatment groups (p < 0.05). A decrease in the mRNA and protein levels of BDNF and GluN3A was observed in all treatment groups, but the statistical analysis of RT-PCR did not reveal significant differences between the control and treatment groups (p > 0.05). These results indicate that piracetam can prevent cerebral palsy in a foetal rat model established via prenatal LPS injection, as assessed by the protein expression of BDNF and GluN3A mRNA. https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/9588BDNF, Cerebral palsy, GluN3A, piracetam, rats.
spellingShingle Dudy Aldiansyah
Sarma Nursani Lumbanraja
Khairul Putra Surbakti
Isti Ilmiati Fujiati
Agus Sulistyono
The Effect of Piracetam Administration on Cerebral Palsy Prevention in Rat Fetuses Born To Pregnant Rats by Determining Bdnf Levels in Brain Tissue
مجلة بغداد للعلوم
BDNF, Cerebral palsy, GluN3A, piracetam, rats.
title The Effect of Piracetam Administration on Cerebral Palsy Prevention in Rat Fetuses Born To Pregnant Rats by Determining Bdnf Levels in Brain Tissue
title_full The Effect of Piracetam Administration on Cerebral Palsy Prevention in Rat Fetuses Born To Pregnant Rats by Determining Bdnf Levels in Brain Tissue
title_fullStr The Effect of Piracetam Administration on Cerebral Palsy Prevention in Rat Fetuses Born To Pregnant Rats by Determining Bdnf Levels in Brain Tissue
title_full_unstemmed The Effect of Piracetam Administration on Cerebral Palsy Prevention in Rat Fetuses Born To Pregnant Rats by Determining Bdnf Levels in Brain Tissue
title_short The Effect of Piracetam Administration on Cerebral Palsy Prevention in Rat Fetuses Born To Pregnant Rats by Determining Bdnf Levels in Brain Tissue
title_sort effect of piracetam administration on cerebral palsy prevention in rat fetuses born to pregnant rats by determining bdnf levels in brain tissue
topic BDNF, Cerebral palsy, GluN3A, piracetam, rats.
url https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/9588
work_keys_str_mv AT dudyaldiansyah theeffectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue
AT sarmanursanilumbanraja theeffectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue
AT khairulputrasurbakti theeffectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue
AT istiilmiatifujiati theeffectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue
AT agussulistyono theeffectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue
AT dudyaldiansyah effectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue
AT sarmanursanilumbanraja effectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue
AT khairulputrasurbakti effectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue
AT istiilmiatifujiati effectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue
AT agussulistyono effectofpiracetamadministrationoncerebralpalsypreventioninratfetusesborntopregnantratsbydeterminingbdnflevelsinbraintissue